|
1. JAPAN
Collection/compilation agency: Statistics Bureau, Ministry of Public Management, Home Affairs, Posts and Telecommunications, Japan (formerly known as the: Statistics Bureau, Management and Coordination Agency of the Government of Japan)
Collection/compilation type: R&D Survey on Life Sciences.
Variables:
Scope: Companies, research institutes, universities and colleges.
Frequency: Annual. Questions were incorporated in 1995/1996. The last time these questions were included was for 1997/1998.
Periodicity: Annual.
Classification used: N/A
Definition used: Gene recombination research and development (recombinant DNA research and development) means research and development relating to creation of cells having new genetic traits by recombining with a gene of a different species after cutting and joining genes from certain organisms (DNA, deoxyribonucleic acid, chemical substance of a gene), using enzyme, and then transplanting it into a cell of a different species of organism. The results can be applied to basic research and development and medicine, agriculture, industry, and energy and environmental protection.
Output: Report on the Survey of Research and Development, Annual.
Contact comments: N/A
Contact details: http://www.stat.go.jp/english/index.htm
__________
2. JAPAN
Collection/compilation agency: Japan Bioindustry Association (JBA)
Collection/compilation type: Biotechnology Industry Survey
Variables:
-
Number of companies
-
Company profile
-
Product profile:
Scope: Business enterprise.
Frequency: Annual as of 1997.
Periodicity: Annual.
Classification used: “Biotechnology” in this survey is the technology that utilises or imitates the function of living organisms to transform substances; exchange, treat, and transmit biological information; or exchange energy. Those technologies are utilised and practically applied in the following fields:
-
Biochemical processes: useful substance production, energy generation, environmental remediation, etc.
-
Creation of substances, materials, enzymes, microbes, and plant and animal with superior new functions.
-
Use of biological mechanism: genetic therapy, diagnostic technology, artificial organs, etc.
-
Highly sensitive and specific detection, measurement, and information transmission technologies utilising or imitating biological functions: biosensors, biocomputers, etc.
-
Technology to evaluate and analyse useful substances: evaluation of biologically active substances such as pharmaceuticals;
-
Research to elucidate biological mechanism.
The biotechnology targeted in this survey includes not only new biotechnology such as recombinant DNA technology, cell fusion, and cultivation of plant and animal cells, but also the conventional technology used in fermentation and brewing, cultivation, and mutagenesis.
“Biotechnology related products” in this survey are as follows.
-
Products produced at your firm, using processes employing biotechnology.
-
Products that although not produced using processes employing biotechnology in your firm, use materials that have been manufactured through biotechnology.
-
Products that although not produced using processes employing biotechnology in your firm, are using biotechnology as the main technology in the research and development stages.
-
Products whose materials purchased were produced using biotechnology such as described in (1)-(3), excluding those exported from foreign countries.
-
Instruments, machinery, facilities, and plants involved in production processes using biotechnology or biotechnology related research and development.
-
Services related to biotechnology such as analyses, tests, software, etc.
Output: Annual report, Fundamental Survey on Creation of Biotechnology Industry, (Japanese version only).
Contact comments: As of 2000, the JBA survey on the biotechnology industry is conducted under contract by the Ministry of Economy, Trade and Industry (METI).
Contact details: http://www.jba.or.jp
Survey attached in annex
|
